Clinical Trial Update: Growth Hormone Therapy for Muscle Regeneration in Severely Burned Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating growth hormone therapy for muscle regeneration in severely burned patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Growth hormone therapy (somatropin)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Burns, Growth Hormone Treatment | Phase 2, Phase 3 | Status: COMPLETED